Fibrosis/Cirrhosis
Fibrosis & Cirrhosis
FibroScan Liver Stiffness Measurement Predicts Liver Failure and Death
- Details
- Category: Fibrosis & Cirrhosis
- Published on Friday, 13 July 2012 00:00
- Written by Liz Highleyman
Transient elastography, better known as FibroScan, is an accurate method for predicting liver-related clinical events and death in HIV positive people coinfected with hepatitis C virus (HCV), according to a study described in the July 2012 issue of Hepatology.
Insulin Resistance Linked to Liver Disease Progression in HIV/HCV Coinfected Patients
- Details
- Category: Fibrosis & Cirrhosis
- Published on Friday, 13 July 2012 00:00
- Written by Liz Highleyman
Insulin resistance is common among HIV positive people with hepatitis C virus (HCV) coinfection and is strongly associated with progression to liver fibrosis over time, Canadian researchers reported in the June 27, 2012, advance online edition of AIDS.
Coffee May Reduce Fibrosis in People with Fatty Liver Disease
- Details
- Category: Fibrosis & Cirrhosis
- Published on Tuesday, 07 February 2012 00:00
- Written by Liz Highleyman
A new study published in the February 2012 issue of Hepatology adds to the evidence that drinking caffeinated coffee may help slow or prevent progression of liver damage, this time in people with nonalcoholic fatty liver disease (NAFLD).
Hepatitis C Treatment May Improve Liver Fibrosis Even Without a Cure
- Details
- Category: HCV Treatment
- Published on Tuesday, 03 July 2012 00:00
- Written by Liz Highleyman
Experiencing a large decrease in hepatitis C virus (HCV) viral load after starting interferon-based therapy was associated with reduced liver inflammation and lower risk of fibrosis progression, even among patients who did not achieve sustained virological response, researchers reported in the June 12, 2012, advance edition of the American Journal of Gastroenterology.
AASLD 2011: Do Hepatitis C Patients with Cirrhosis Benefit from Adding Telaprevir?
- Details
- Category: HCV Treatment
- Published on Tuesday, 15 November 2011 00:00
- Written by Liz Highleyman
Adding telaprevir to pegylated interferon/ribavirin increased the likelihood of a cure for genotype 1 chronic hepatitis C patients with liver cirrhosis in the REALIZE trial, according to data presented at the American Association for the Study of Liver Diseases Liver Meeting (AASLD 2011) last week in San Francisco.
More Articles...
- EACS 2011: Antiretroviral Therapy Reduces Liver Fibrosis Progression in HIV/HCV Coinfected People
- ICAAC 2011: Interferon May Reduce Liver Disease Progression in HIV/HCV Coinfected Relapsers
- ICAAC 2011: Didanosine, Higher HCV Viral Load Predict Liver Fibrosis in HIV/HCV Coinfected People
- Caffeine and Liver Disease in People with Hepatitis C
Web Design and Development by